HFYCX
Price
$12.01
Change
+$0.03 (+0.25%)
Updated
Jun 5 closing price
Net Assets
2.31B
VIHAX
Price
$38.59
Change
+$0.05 (+0.13%)
Updated
Jun 5 closing price
Net Assets
10.99B
Interact to see
Advertisement

HFYCX vs VIHAX

Header iconHFYCX vs VIHAX Comparison
Open Charts HFYCX vs VIHAXBanner chart's image
Hartford Schroders Intl Multi-Cp Val C
Price$12.01
Change+$0.03 (+0.25%)
VolumeN/A
Net Assets2.31B
Vanguard Intl Hi Div Yld Adm
Price$38.59
Change+$0.05 (+0.13%)
VolumeN/A
Net Assets10.99B
HFYCX vs VIHAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HFYCX vs. VIHAX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFYCX is a Buy and VIHAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIHAX has more cash in the bank: 11B vs. HFYCX (2.31B). VIHAX pays higher dividends than HFYCX: VIHAX (4.14) vs HFYCX (1.59). HFYCX was incepted earlier than VIHAX: HFYCX (9 years) vs VIHAX (9 years). HFYCX (1.87) is less costly to investors than VIHAX (0.17). HFYCX is a more actively managed with annual turnover of: 112.00 vs. VIHAX (11.00). HFYCX has a lower initial minimum investment than VIHAX: HFYCX (2000) vs VIHAX (3000). HFYCX annual gain was more profitable for investors over the last year : 17.68 vs. VIHAX (13.94). HFYCX return over 5 years is better than : 61.14 vs. VIHAX (54.33).
HFYCXVIHAXHFYCX / VIHAX
Total Expense Ratio1.870.171,100%
Annual Report Gross Expense Ratio1.870.171,100%
Fund Existence9 years9 years-
Gain YTD20.61017.675117%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets2.31B11B21%
Annual Yield % from dividends1.594.1438%
Returns for 1 year17.6813.94127%
Returns for 3 years29.7725.56116%
Returns for 5 years61.1454.33113%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTIX28.58N/A
N/A
Fidelity Advisor Biotechnology I
MNHIX25.90N/A
N/A
Manning & Napier Pro-Blend Max Term I
HMDFX27.33N/A
N/A
Hartford MidCap F
FWMNX17.07N/A
N/A
Fidelity Advisor Women's Leadership I
HLXCX11.31N/A
N/A
Harding Loevner Emer Mkt ex Chn Instl